FDA panel to review saline implants in March
This article was originally published in Clinica
Executive Summary
The US FDA's general and plastic surgery advisory panel will review two PMA applications for saline breast implants on March 1-3. Two Santa Barbara, California, companies, Mentor and Inamed's McGhan Medical, submitted PMAs with extensive clinical data in November to comply with a recent FDA regulation in order to continue selling the popular products.